Literature DB >> 28124609

Recombinant Expression, Functional Characterization of Two Scorpion Venom Toxins with Three Disulfide Bridges from the Chinese Scorpion Buthus martensii Karsch.

Shengguo Lin, Xuelin Wang, Xueyao Hu, Yongshan Zhao, Mingyi Zhao, Jinghai Zhang1, Yong Cui2.   

Abstract

Scorpion venom contains a large variety of biologically active peptides. However, most of these peptides have not been identified and characterized. Peptides with three disulfide bridges, existing in the scorpion venom, have not been studied in detail and have been poorly characterized until now. Here, we report the recombinant expression and functional characterization of two kinds of venom peptides (BmKBTx and BmNaL-3SS2) with three disulfide bridges. This study adopted an effective Escherichia coli system. The genes for BmKBTx and BmNaL-3SS2 were obtained by polymerase chain reaction and cloned to the pSYPU-1b vector. After expression and purification, the two recombinant proteins were subjected to an analgesic activity assay in mice and whole-cell patchclamp recording of hNav1.7-CHO cell lines. Functional tests showed that BmKBTx and BmNaL- 3SS2 have analgesic activity in mice and can interact with the hNav1.7 subtype of the voltage-gated sodium channel (VGSC). Scorpion venom is rich in bioactive proteins, but most of their functions are unknown to us. This study has increased our knowledge of these novel disulfide-bridged peptides (DBPs) and their biological activities. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  BmKBTx; BmNaL-3SS2; analgesic activity; disulfide bridge; electrophysiology; hNav1.7; recombinant expression

Mesh:

Substances:

Year:  2017        PMID: 28124609     DOI: 10.2174/0929866524666170117142404

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  4 in total

1.  A mutant of the Buthus martensii Karsch antitumor-analgesic peptide exhibits reduced inhibition to hNav1.4 and hNav1.5 channels while retaining analgesic activity.

Authors:  Yijia Xu; Xiangxue Meng; Xue Hou; Jianfang Sun; Xiaohua Kong; Yuqi Sun; Zeyu Liu; Yuanyuan Ma; Ye Niu; Yongbo Song; Yong Cui; Mingyi Zhao; Jinghai Zhang
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

2.  Cloning, expression and identification of KTX-Sp4, a selective Kv1.3 peptidic blocker from Scorpiops pococki.

Authors:  Yan Zou; Feng Zhang; Yaxian Li; Yuanfang Wang; Yi Li; Zhengtao Long; Shujuan Shi; Li Shuai; Jiukai Liu; Zhiyong Di; Shijin Yin
Journal:  Cell Biosci       Date:  2017-11-06       Impact factor: 7.133

Review 3.  Scorpion Venom: Detriments and Benefits.

Authors:  Shirin Ahmadi; Julius M Knerr; Lídia Argemi; Karla C F Bordon; Manuela B Pucca; Felipe A Cerni; Eliane C Arantes; Figen Çalışkan; Andreas H Laustsen
Journal:  Biomedicines       Date:  2020-05-12

Review 4.  Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation.

Authors:  Jesús Borrego; Adam Feher; Norbert Jost; Gyorgy Panyi; Zoltan Varga; Ferenc Papp
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.